The Department of Defense maintains a Peer Reviewed Medical Research Program to support research across the full range of science and medicine, with an underlying goal of enhancing the health, care, and well-being of military service members, veterans, retirees, and their family members. Projects related to peripheral neuropathy are eligible to apply for funding through this program. 

FY23 award mechanisms and pre-application deadlines:

• Clinical Trial (no $ limit): April 12
• Discovery ($200,000 maximum): March 29
• Focused Program ($7.2 million maximum): April 12
• Investigator-Initiated Research Award ($1.6 million maximum): April 19
• Lifestyle and Behavioral Health Interventions ($3 million maximum): April 19
• Technology/Therapeutic Development ($2 million): April 19

Most of the full applications are due April 26 and July 19, 2023, depending on the grant mechanism.

Learn More

Candidate Requirements: Scientists or clinicians with an innovative idea relevant to immunoglobulin research in neurology are invited to apply for the SPIN Award. Applications are encouraged from both individuals and teams who may be conducting research at hospitals, universities or independent institutions. View full details at www.spin-awards.com.

Applications for the SPIN Awards 2023 will be accepted between August 1, 2022 and January 31, 2023.

Hunter’s CMT4B3 Research Foundation will grant awards to principal investigators, physician residents, hospitals, universities and clinicians who are interested in studying CMT4B3. Our grants are intended to help researchers explore novel ideas and answer questions related to the clinical aspects, therapies and/or genetic causes of CMT4B3.

Research proposals will be carefully vetted by the Scientific Advisory Board. The Board evaluates each proposal based on the excellence of the investigator, the work plan and the environment, as well as the project’s ability to be translated into treatments for people with CMT4B3.  For more information on this opportunity, please click here.  Questions? Please contact Alessandra Bolino, bolino.alessandra@hsr.it  and  Robin Schultz, info@cmt4b3research.org.

As part of the GBS|CIDP Foundation International’s mission to provide education and support research, we offer research grants to qualified applicants. Through the generosity of these many individual contributors, to whom the Foundation is most grateful, we are able to offer this Research Grant Program. The GBS|CIDP Foundation International has worldwide representation, sharing resources with local support group chapters nationally and internationally.

Foundation interests include GBS, both demyelinating and axonal variants, Miller Fisher syndrome, CIDP, Multifocal Motor Neuropathy, and others. Research interests cover a broad range of subjects including development of methods to more rapidly diagnose these disorders, identification of mechanisms involved in the pathogenesis, development of more effective treatments to limit the disease process, prevent complications and reduce long-term adverse sequelae.  For additional information, please contact:  grants@gbs-cidp.org

GBS|CIDP Foundation International Discovery Award:  The GBS|CIDP Foundation believes in supporting research on GBS, CIDP, and variants by funding grants for projects that contribute to the knowledge of, and towards an eventual cure for, GBS, CIDP, and variants.  We invite all researchers to apply for this

2-year, $100k/year grant opportunity.  Letters of Intent due: November 1.

Submit Letter of Intent:   https://www.gbs-cidp.org/research/letter-of-intent 

GBS|CIDP Foundation International Elevation Award:  The GBS|CIDP Foundation believes in supporting research on GBS, CIDP, and variants by funding grants for projects that contribute to the knowledge of, and towards an eventual cure for, GBS, CIDP, and variants.  We invite all researchers to apply for this

1-year, $50k/year grant opportunity.  Letters of Intent due: November 1.

Submit Letter of Intent:   https://www.gbs-cidp.org/research/letter-of-intent

GBS|CIDP Foundation International MMN Elevation Award– In 2022 the Foundation initiated fundraising efforts to support research specifically for better treatments and diagnosis of Multifocal Motor Neuropathy. As a result of these efforts, we are announcing the first ever Request for Applications for a MMN specific grant.  We invite all researchers to apply for this 1-year, $50k/year grant opportunity. 

Letters of Intent due: November 1.

Submit Letter of Intent:   https://www.gbs-cidp.org/research/letter-of-intent

GBS|CIDP Foundation International Benson Fellowship: The Benson Fellowship is a three-year fellowship that provides an opportunity for talented scientists to engage in peripheral nerve of study. The aim of the scheme is to provide funds (up to $150k per year for three years) to enable clinicians or non-clinical scientists in training or having recently completed training to engage in a substantial research project in the field of inflammatory neuropathy at a Centre or Centers of Excellence or an Institution approved by the committee. Preference will be given to candidates who intend to pursue a long-term career in this field. Letters of Intent due: September 1, 2024

The next fellowship cycle begins January 2025

Submit Letter of Intent: https://www.gbs-cidp.org/research/benson-letter-of-intent/

DOD PRMRP: The Department of Defense maintains a Peer Reviewed Medical Research Program to support research across the full range of science and medicine, with an underlying goal of enhancing the health, care, and well-being of military Service members, Veterans, retirees, and their family members. Projects related to Peripheral Neuropathy are eligible to apply for funding through this program thanks to the partnership between the Foundation and key Congressional partners who recognize a relationship between GBS and Service members.  

https://cdmrp.army.mil/funding/prmrp

RFA-AT-23-001 Funding Opportunity Announcement—HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)

Purpose: To support multisite embedded pragmatic or implementation trials to inform the uptake of pharmacologic, nonpharmacologic, and/or multicomponent approaches for acute and/or chronic SCD pain management in health care systems that serve the SCD population.

RFA-AT-23-002 Funding Opportunity Announcement—HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required)

Purpose: To support multisite effectiveness clinical trials of pharmacologic, nonpharmacologic, and/or multicomponent approaches for acute and/or chronic SCD pain management, allowing continued opioid pain management as needed.

Interested applicants can register for a technical assistance webinar on October 4, 2022 from 2:00 – 3:00 p.m. ET.

Our Frequently Asked Questions document shares tips for applying and outlines research interests of each participating NIH organization. The application deadline for both FOAs is November 21, 2022.

If you have further questions, please feel free to email Dr. Wendy Weber, (weberwj@mail.nih.gov), or Dr. Sekai Chideya (Sekai.chideya@nih.gov) from NCCIH or  Dr. William Tonkins (william.tonkins@nih.gov), or Dr. Susan Shero (sheros@nhlbi.nih.gov) from NHLBI.